Special Access Scheme Archives | Page 3 of 4 | Cannabiz

Growth of pastilles accelerates as SAS approvals get off to strong start in 2025

by Steve Jones February 17, 2025February 17, 2025

The Therapeutic Goods Administration (TGA) rubber stamped more than 16,000 Special Access Scheme applications in January […]

SAS-B deep dive: approvals soar in ’24 with category five medicine leading the charge

by Steve Jones January 22, 2025January 22, 2025

TGA ‘exploring’ patient safety but stresses importance of ‘timely access’ to medicinal cannabis

by Steve Jones January 14, 2025January 14, 2025

Defending the role of cannabis as a public and community good: the call to action in 2025

by Andrew Proudfoot January 9, 2025January 9, 2025

Medical cannabis can be life changing, let’s not lose all we have gained

by Dr Nic Giummarra December 11, 2024December 11, 2024

Pastilles continue steady SAS-B growth but flower retains top spot

by Steve Jones December 4, 2024April 11, 2025

Health bodies urge TGA to remove medical cannabis from SAS as ‘alarm’ grows over ‘highly potent’ THC

by Steve Jones November 22, 2024November 22, 2024

NSW SAS-B approvals below annual average following crackdown

by Steve Jones October 2, 2024October 2, 2024

May SAS-B approvals hold steady as THC-only product remains dominant

by Steve Jones June 3, 2024June 3, 2024

Pastilles gaining in popularity as SAS-B approvals maintain strong start to 2024

by Steve Jones May 6, 2024July 16, 2024